A citation-based method for searching scientific literature

David E Reuss, Yasin Mamatjan, Daniel Schrimpf, David Capper, Volker Hovestadt, Annekathrin Kratz, Felix Sahm, Christian Koelsche, Andrey Korshunov, Adriana Olar, Christian Hartmann, Jaap C Reijneveld, Pieter Wesseling, Andreas Unterberg, Michael Platten, Wolfgang Wick, Christel Herold-Mende, Kenneth Aldape, Andreas von Deimling. Acta Neuropathol 2015
Times Cited: 179



Christian Hartmann, Jochen Meyer, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Jörg Felsberg, Marietta Wolter, Christian Mawrin, Wolfgang Wick, Michael Weller, Christel Herold-Mende, Andreas Unterberg, Judith W M Jeuken, Peter Wesseling, Guido Reifenberger, Andreas von Deimling. Acta Neuropathol 2009
Times Cited: 797




List of shared articles



Times cited

IDH1/2 Mutations in Patients With Diffuse Gliomas: A Single Centre Retrospective Massively Parallel Sequencing Analysis.
Zuzana Sporikova, Rastislav Slavkovsky, Lucie Tuckova, Ondrej Kalita, Magdalena Megova Houdova, Jiri Ehrmann, Marian Hajduch, Lumir Hrabalek, Miroslav Vaverka. Appl Immunohistochem Mol Morphol 2022
0

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
Eike Steidl, Katharina Filipski, Pia S Zeiner, Marlies Wagner, Emmanouil Fokas, Marie-Therese Forster, Michael W Ronellenfitsch, Iris Divé, Joachim P Steinbach, Patrick N Harter,[...]. J Cancer Res Clin Oncol 2021
1

ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging.
Nils C Nuessle, Felix Behling, Ghazaleh Tabatabai, Salvador Castaneda Vega, Jens Schittenhelm, Ulrike Ernemann, Uwe Klose, Johann-Martin Hempel. J Clin Med 2021
1


Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine.
Yu Han, Wen Wang, Yang Yang, Ying-Zhi Sun, Gang Xiao, Qiang Tian, Jin Zhang, Guang-Bin Cui, Lin-Feng Yan. Front Neurosci 2020
9

Gray Areas in the Gray Matter: IDH1/2 Mutations in Glioma.
Martin J van den Bent, Ingo K Mellinghoff, Ranjit S Bindra. Am Soc Clin Oncol Educ Book 2020
4

Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas.
Paola Feraco, Antonella Bacci, Patrizia Ferrazza, Luc van den Hauwe, Riccardo Pertile, Salvatore Girlando, Mattia Barbareschi, Cesare Gagliardo, Alessio Giuseppe Morganti, Benedetto Petralia. Diagnostics (Basel) 2020
4



In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.
Johann-Martin Hempel, Jens Schittenhelm, Uwe Klose, Benjamin Bender, Georg Bier, Marco Skardelly, Ghazaleh Tabatabai, Salvador Castaneda Vega, Ulrike Ernemann, Cornelia Brendle. Clin Neuroradiol 2019
11

Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
K Ina Ly, Derek H Oakley, Alexander B Pine, Matthew P Frosch, Sy Han Chiou, Rebecca A Betensky, Stuart R Pomerantz, Fred H Hochberg, Tracy T Batchelor, Daniel P Cahill,[...]. Oncologist 2019
2

IDH mutant astrocytoma: biomarkers for prognostic stratification and the next frontiers.
S Brandner, Z Jaunmuktane. Neuropathol Appl Neurobiol 2019
2

The Misclassification of Diffuse Gliomas: Rates and Outcomes.
J Bryan Iorgulescu, Matthew Torre, Maya Harary, Timothy R Smith, Ayal A Aizer, David A Reardon, Jill S Barnholtz-Sloan, Arie Perry. Clin Cancer Res 2019
22

Accelerated progression of IDH mutant glioma after first recurrence.
Julie J Miller, Franziska Loebel, Tareq A Juratli, Shilpa S Tummala, Erik A Williams, Tracy T Batchelor, Isabel Arrillaga-Romany, Daniel P Cahill. Neuro Oncol 2019
21

Biomarkers in tumors of the central nervous system - a review.
David Scheie, Huda Haidar Abdallah Kufaishi, Helle Broholm, Eva Løbner Lund, Karin de Stricker, Linea C Melchior, Morten Grauslund. APMIS 2019
6

Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.
Johann-Martin Hempel, Cornelia Brendle, Benjamin Bender, Georg Bier, Mareen Sarah Kraus, Marco Skardelly, Hardy Richter, Franziska Eckert, Jens Schittenhelm, Ulrike Ernemann,[...]. Eur J Radiol 2019
11

Genetic and molecular epidemiology of adult diffuse glioma.
Annette M Molinaro, Jennie W Taylor, John K Wiencke, Margaret R Wrensch. Nat Rev Neurol 2019
196


Effect of Perfusion on Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of Integrated 2016 WHO Glioma Grades : A Cross-Sectional Observational Study.
Johann-Martin Hempel, Jens Schittenhelm, Cornelia Brendle, Benjamin Bender, Georg Bier, Marco Skardelly, Ghazaleh Tabatabai, Salvador Castaneda Vega, Ulrike Ernemann, Uwe Klose. Clin Neuroradiol 2018
6

In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.
J-M Hempel, J Schittenhelm, S Bisdas, C Brendle, B Bender, G Bier, M Skardelly, G Tabatabai, S Castaneda Vega, U Ernemann,[...]. J Neuroradiol 2018
27

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Kosuke Aoki, Hideo Nakamura, Hiromichi Suzuki, Keitaro Matsuo, Keisuke Kataoka, Teppei Shimamura, Kazuya Motomura, Fumiharu Ohka, Satoshi Shiina, Takashi Yamamoto,[...]. Neuro Oncol 2018
123

Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.
S Schäfer, F Behling, M Skardelly, M Koch, I Ott, F Paulsen, G Tabatabai, J Schittenhelm. Neuropathol Appl Neurobiol 2018
7

Neurological update: gliomas and other primary brain tumours in adults.
Sebastian Brandner, Zane Jaunmuktane. J Neurol 2018
18